248 related articles for article (PubMed ID: 34171297)
21. Virus Infection Triggers MAVS Polymers of Distinct Molecular Weight.
Zamorano Cuervo N; Osseman Q; Grandvaux N
Viruses; 2018 Jan; 10(2):. PubMed ID: 29385716
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis C Virus Infection Is Inhibited by a Noncanonical Antiviral Signaling Pathway Targeted by NS3-NS4A.
Vazquez C; Tan CY; Horner SM
J Virol; 2019 Dec; 93(23):. PubMed ID: 31534039
[TBL] [Abstract][Full Text] [Related]
23. The Human Papillomavirus E6 Oncoprotein Targets USP15 and TRIM25 To Suppress RIG-I-Mediated Innate Immune Signaling.
Chiang C; Pauli EK; Biryukov J; Feister KF; Meng M; White EA; Münger K; Howley PM; Meyers C; Gack MU
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263274
[TBL] [Abstract][Full Text] [Related]
24. Cyclophilin A-regulated ubiquitination is critical for RIG-I-mediated antiviral immune responses.
Liu W; Li J; Zheng W; Shang Y; Zhao Z; Wang S; Bi Y; Zhang S; Xu C; Duan Z; Zhang L; Wang YL; Jiang Z; Liu W; Sun L
Elife; 2017 Jun; 6():. PubMed ID: 28594325
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-33/33* inhibit the activation of MAVS through AMPK in antiviral innate immunity.
Liu D; Tan Q; Zhu J; Zhang Y; Xue Y; Song Y; Liu Y; Wang Q; Lai L
Cell Mol Immunol; 2021 Jun; 18(6):1450-1462. PubMed ID: 31767975
[TBL] [Abstract][Full Text] [Related]
26. Requirement of NOX2 and reactive oxygen species for efficient RIG-I-mediated antiviral response through regulation of MAVS expression.
Soucy-Faulkner A; Mukawera E; Fink K; Martel A; Jouan L; Nzengue Y; Lamarre D; Vande Velde C; Grandvaux N
PLoS Pathog; 2010 Jun; 6(6):e1000930. PubMed ID: 20532218
[TBL] [Abstract][Full Text] [Related]
27. NLRX1 Mediates MAVS Degradation To Attenuate the Hepatitis C Virus-Induced Innate Immune Response through PCBP2.
Qin Y; Xue B; Liu C; Wang X; Tian R; Xie Q; Guo M; Li G; Yang D; Zhu H
J Virol; 2017 Dec; 91(23):. PubMed ID: 28956771
[TBL] [Abstract][Full Text] [Related]
28. Human Respiratory Syncytial Virus NS 1 Targets TRIM25 to Suppress RIG-I Ubiquitination and Subsequent RIG-I-Mediated Antiviral Signaling.
Ban J; Lee NR; Lee NJ; Lee JK; Quan FS; Inn KS
Viruses; 2018 Dec; 10(12):. PubMed ID: 30558248
[TBL] [Abstract][Full Text] [Related]
29. The hepatitis B virus X protein disrupts innate immunity by downregulating mitochondrial antiviral signaling protein.
Wei C; Ni C; Song T; Liu Y; Yang X; Zheng Z; Jia Y; Yuan Y; Guan K; Xu Y; Cheng X; Zhang Y; Yang X; Wang Y; Wen C; Wu Q; Shi W; Zhong H
J Immunol; 2010 Jul; 185(2):1158-68. PubMed ID: 20554965
[TBL] [Abstract][Full Text] [Related]
30. Prmt7 promotes myoblast differentiation via methylation of p38MAPK on arginine residue 70.
Jeong HJ; Lee SJ; Lee HJ; Kim HB; Anh Vuong T; Cho H; Bae GU; Kang JS
Cell Death Differ; 2020 Feb; 27(2):573-586. PubMed ID: 31243342
[TBL] [Abstract][Full Text] [Related]
31. RNF34 functions in immunity and selective mitophagy by targeting MAVS for autophagic degradation.
He X; Zhu Y; Zhang Y; Geng Y; Gong J; Geng J; Zhang P; Zhang X; Liu N; Peng Y; Wang C; Wang Y; Liu X; Wan L; Gong F; Wei C; Zhong H
EMBO J; 2019 Jul; 38(14):e100978. PubMed ID: 31304625
[TBL] [Abstract][Full Text] [Related]
32. DDIT3 Targets Innate Immunity via the DDIT3-OTUD1-MAVS Pathway To Promote Bovine Viral Diarrhea Virus Replication.
Wang S; Hou P; Pan W; He W; He DC; Wang H; He H
J Virol; 2021 Feb; 95(6):. PubMed ID: 33361422
[TBL] [Abstract][Full Text] [Related]
33. Virus subtype-specific suppression of MAVS aggregation and activation by PB1-F2 protein of influenza A (H7N9) virus.
Cheung PH; Lee TT; Kew C; Chen H; Yuen KY; Chan CP; Jin DY
PLoS Pathog; 2020 Jun; 16(6):e1008611. PubMed ID: 32511263
[TBL] [Abstract][Full Text] [Related]
34. Regulation of MAVS Expression and Signaling Function in the Antiviral Innate Immune Response.
Ren Z; Ding T; Zuo Z; Xu Z; Deng J; Wei Z
Front Immunol; 2020; 11():1030. PubMed ID: 32536927
[TBL] [Abstract][Full Text] [Related]
35. Lymphocytic Choriomeningitis Virus Differentially Affects the Virus-Induced Type I Interferon Response and Mitochondrial Apoptosis Mediated by RIG-I/MAVS.
Pythoud C; Rothenberger S; Martínez-Sobrido L; de la Torre JC; Kunz S
J Virol; 2015 Jun; 89(12):6240-50. PubMed ID: 25833049
[TBL] [Abstract][Full Text] [Related]
36.
Seo J; Park YS; Kweon TH; Kang J; Son S; Kim HB; Seo YR; Kang MJ; Yi EC; Lee YH; Kim JH; Park B; Yang WH; Cho JW
Front Immunol; 2020; 11():589259. PubMed ID: 33603735
[TBL] [Abstract][Full Text] [Related]
37. IRTKS negatively regulates antiviral immunity through PCBP2 sumoylation-mediated MAVS degradation.
Xia P; Wang S; Xiong Z; Ye B; Huang LY; Han ZG; Fan Z
Nat Commun; 2015 Sep; 6():8132. PubMed ID: 26348439
[TBL] [Abstract][Full Text] [Related]
38. The mitochondrial ubiquitin ligase MARCH5 resolves MAVS aggregates during antiviral signalling.
Yoo YS; Park YY; Kim JH; Cho H; Kim SH; Lee HS; Kim TH; Sun Kim Y; Lee Y; Kim CJ; Jung JU; Lee JS; Cho H
Nat Commun; 2015 Aug; 6():7910. PubMed ID: 26246171
[TBL] [Abstract][Full Text] [Related]
39. Smurf2 negatively modulates RIG-I-dependent antiviral response by targeting VISA/MAVS for ubiquitination and degradation.
Pan Y; Li R; Meng JL; Mao HT; Zhang Y; Zhang J
J Immunol; 2014 May; 192(10):4758-64. PubMed ID: 24729608
[TBL] [Abstract][Full Text] [Related]
40. Dengue Virus Subverts Host Innate Immunity by Targeting Adaptor Protein MAVS.
He Z; Zhu X; Wen W; Yuan J; Hu Y; Chen J; An S; Dong X; Lin C; Yu J; Wu J; Yang Y; Cai J; Li J; Li M
J Virol; 2016 Aug; 90(16):7219-7230. PubMed ID: 27252539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
